Arkansas House Bill 1570 (2021)
Legislation in Arkansas regarding transgender healthcare

Arkansas House Bill 1570, also known as the Save Adolescents from Experimentation (SAFE) Act, is a piece of legislation passed in the state of Arkansas in 2021. The bill is notable for its focus on restricting healthcare options for transgender minors, specifically targeting gender-affirming treatments.
Legislative History[edit]
The bill was introduced in the Arkansas House of Representatives in early 2021. It was sponsored by Representative Robin Lundstrum and Senator Alan Clark. The bill passed the House on March 10, 2021, and the Arkansas Senate on March 29, 2021. Despite a veto by Governor Asa Hutchinson, the Arkansas legislature overrode the veto on April 6, 2021, making it law.
Provisions of the Bill[edit]
Arkansas House Bill 1570 prohibits healthcare professionals from providing gender-affirming treatments to individuals under the age of 18. This includes the prescription of puberty blockers, hormone therapy, and gender-affirming surgeries. The bill also prevents the use of public funds for such treatments and prohibits insurance coverage for these procedures for minors.
Impact and Controversy[edit]
The bill has been the subject of significant controversy and debate. Proponents argue that it protects minors from making irreversible decisions about their bodies at a young age. Opponents, including major medical organizations, argue that it denies necessary healthcare to transgender youth and could lead to negative mental health outcomes.
The passage of the bill has led to legal challenges, with opponents arguing that it violates the constitutional rights of transgender individuals. The law has been temporarily blocked by a federal judge pending further review.
Reactions[edit]
The bill has drawn reactions from various stakeholders, including healthcare professionals, advocacy groups, and political figures. Many medical organizations, such as the American Academy of Pediatrics and the American Medical Association, have opposed the bill, citing concerns about the well-being of transgender youth.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian